LENZ Therapeutics, Inc. (LENZ) › Shareholders' EquityLENZ Therapeutics, Inc. (LENZ) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$2.22M2020: -$65.41M2021: $384.05M2022: -$24.17M2023: -$92.71M2024: $204.08M2025: $284.34M$284.34M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$284.34M+39.3%2024$204.08M+320.1%2023-$92.71M-283.6%2022-$24.17M-106.3%2021$384.05M+687.2%2020-$65.41M-2849.0%2019-$2.22M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share